Home LiteratureArticle Details
PMID: 12714683 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Gene expression profiles of human breast cancer progression.

Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P, Payette T, Pistone M, Stecker K, Zhang BM, Zhou YX, Varnholt H, Smith B, Gadd M, Chatfield E, Kessler J, Baer TM, Erlander MG, Sgroi DC

Abstract

Although distinct pathological stages of breast cancer have been described, the molecular differences among these stages are largely unknown. Here, through the combined use of laser capture microdissection and DNA microarrays, we have generated in situ gene expression profiles of the premalignant, preinvasive, and invasive stages of human breast cancer. Our data reveal extensive similarities at the transcriptome level among the distinct stages of progression and suggest that gene expression alterations conferring the potential for invasive growth are already present in the preinvasive stages. In contrast to tumor stage, different tumor grades are associated with distinct gene expression signatures. Furthermore, a subset of genes associated with high tumor grade is quantitatively correlated with the transition from preinvasive to invasive growth.

MeSH Terms
Breast Neoplasms/genetics,pathology Disease Progression Enzymes/genetics Epithelial Cells/pathology Female Gene Expression Profiling Gene Expression Regulation, Neoplastic Humans Image Processing, Computer-Assisted In Situ Hybridization Neoplasm Proteins/genetics Neoplasm Staging Polymerase Chain Reaction
Chemicals
Enzymes Neoplasm Proteins
Authors & Affiliations
19 authors, click to expand affiliations / ORCID
Ma Xiao-Jun
Applied Genomics Division, Arcturus, 2715 Loker Avenue West, Carlsbad, CA 92008, USA.
Salunga Ranelle
Tuggle J Todd
Gaudet Justin
Enright Edward
McQuary Philip
Payette Terry
Pistone Maria
Stecker Kimberly
Zhang Brian M
Zhou Yi-Xiong
Varnholt Heike
Smith Barbara
Gadd Michelle
Chatfield Erica
Kessler Jessica
Baer Thomas M
Erlander Mark G
Sgroi Dennis C
References (21)
21 references, click to expand
  1. In vivo gene expression profile analysis of human breast cancer progression.
    Cancer Res. 1999 Nov 15;59(22):5656-61 PMID: 10582678
  2. The hallmarks of cancer.
    Cell. 2000 Jan 7;100(1):57-70 PMID: 10647931
  3. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.
    Br J Cancer. 2001 Sep 14;85(6):869-74 PMID: 11556839
  4. Gene expression profiling predicts clinical outcome of breast cancer.
    Nature. 2002 Jan 31;415(6871):530-6 PMID: 11823860
  5. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.
    Nucleic Acids Res. 2002 Feb 15;30(4):e15 PMID: 11842121
  6. Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas.
    Cancer. 2002 Apr 15;94(8):2134-42 PMID: 12001109
  7. A new era in the diagnosis of breast cancer.
    Surg Oncol Clin N Am. 2000 Apr;9(2):233-77 PMID: 10757844
  8. Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreement.
    Mod Pathol. 2000 Jul;13(7):730-5 PMID: 10912931
  9. Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192).
    Am J Clin Oncol. 2001 Feb;24(1):10-8 PMID: 11232942
  10. Histological and biological evolution of human premalignant breast disease.
    Endocr Relat Cancer. 2001 Mar;8(1):47-61 PMID: 11350726
  11. Expression profiling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays.
    Am J Pathol. 2001 Jun;158(6):2005-10 PMID: 11395378
  12. On the origin and progression of ductal carcinoma in the human breast.
    J Natl Cancer Inst. 1973 May;50(5):1111-8 PMID: 4123242
  13. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia.
    Hum Pathol. 1992 Oct;23(10):1095-7 PMID: 1328030
  14. Ductal carcinoma in situ: a proposal for a new classification.
    Semin Diagn Pathol. 1994 Aug;11(3):167-80 PMID: 7831528
  15. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer.
    Cancer Res. 1995 Feb 1;55(3):467-71 PMID: 7834608
  16. Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential.
    Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14036-40 PMID: 8943056
  17. Loss of heterozygosity in normal tissue adjacent to breast carcinomas.
    Science. 1996 Dec 20;274(5295):2057-9 PMID: 8953032
  18. The mammalian ribonucleotide reductase R2 component cooperates with a variety of oncogenes in mechanisms of cellular transformation.
    Cancer Res. 1998 Apr 15;58(8):1650-3 PMID: 9563477
  19. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.
    J Natl Cancer Inst. 1998 May 6;90(9):697-703 PMID: 9586667
  20. Gene expression profiles of laser-captured adjacent neuronal subtypes.
    Nat Med. 1999 Jan;5(1):117-22 PMID: 9883850
  21. A SAGE (serial analysis of gene expression) view of breast tumor progression.
    Cancer Res. 2001 Aug 1;61(15):5697-702 PMID: 11479200
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2003-05-13
Epub
2003-00-24
Pages
5974-9
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC156311
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]